Julia Lainster

Aspect Biosystems, a pioneer in the field of bioprinted tissue therapeutics, recently closed a $115 million Series B financing round aimed at advancing its groundbreaking technology in regenerative medicine. This achievement, led by Dimension and supported by investors such as Novo Nordisk and

As the new year begins, NHS workers continue to face significant pressures and challenges during the winter months, with patient safety concerns becoming more pronounced across various facets of the healthcare system. Several acute trusts have declared critical incidents due to winter pressures,

Navigating the complexities of critical care clinical trials, particularly when facing the issue of "truncation due to death," is crucial for obtaining unbiased, clear, and meaningful results. Patient-centered outcomes affected by death before they can be fully measured pose significant

Artificial intelligence (AI) has garnered significant attention in recent years, particularly within the medical field for its potential to revolutionize various aspects of healthcare. The integration of AI in breast cancer detection promises not only an increase in accuracy but also a potential

The impact of chemicals on child health is a growing concern, with experts calling for a new regulatory framework to address the risks posed by synthetic chemicals and plastics. The current lack of stringent regulations allows potentially harmful products to enter the market, contributing to rising

The healthcare industry is witnessing an unprecedented advancement with the introduction of AI-powered wearable cameras designed to detect and prevent medication errors. These errors are a significant concern, contributing to a substantial number of preventable harms, with medication errors alone

The landscape of clinical trials is on the brink of a significant transformation, driven by the integration of Real World Data (RWD). By 2025, the use of RWD is expected to revolutionize the way clinical trials are conducted, offering new opportunities for efficiency, accuracy, and patient-centric

Recent advancements in imaging technology have caused a significant shift in how high-risk nonmetastatic hormone-sensitive prostate cancer is staged. Conventional imaging techniques, which have long been the standard, might have significantly underestimated the extent of metastasis in these

CAR-T cell therapy has emerged as a groundbreaking approach in cancer treatment, leveraging the body's immune system to target and destroy cancer cells. Since its inception in 2017, this innovative therapy has rapidly evolved, with numerous products reaching commercialization and receiving

The ability of Generative Pre-trained Transformer 4 (GPT-4) to effectively analyze medical notes in multiple languages has garnered significant interest within the medical and technology communities. A recently published comprehensive evaluation study in Lancet Digital Health by a consortium of